Chung‐Wei Yang

406 total citations
25 papers, 309 citations indexed

About

Chung‐Wei Yang is a scholar working on Nephrology, Emergency Medical Services and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chung‐Wei Yang has authored 25 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Nephrology, 9 papers in Emergency Medical Services and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chung‐Wei Yang's work include Central Venous Catheters and Hemodialysis (9 papers), Dialysis and Renal Disease Management (8 papers) and Vascular Procedures and Complications (7 papers). Chung‐Wei Yang is often cited by papers focused on Central Venous Catheters and Hemodialysis (9 papers), Dialysis and Renal Disease Management (8 papers) and Vascular Procedures and Complications (7 papers). Chung‐Wei Yang collaborates with scholars based in Taiwan, Brazil and Netherlands. Chung‐Wei Yang's co-authors include Chih‐Cheng Wu, Chih‐Sheng Lin, F. S. Yeh, Wen-Yeh Hsieh, Kuan‐Yu Hung, Tingyu Liu, Shao‐Yuan Chuang, Mu‐Yang Hsieh, Lin Lin and Chih‐Sheng Lin and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Chung‐Wei Yang

24 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chung‐Wei Yang Taiwan 13 145 129 101 78 45 25 309
Damodar Kumbala United States 10 46 0.3× 72 0.6× 92 0.9× 65 0.8× 25 0.6× 16 227
Yuji Nagura Japan 10 35 0.2× 69 0.5× 194 1.9× 54 0.7× 23 0.5× 37 330
Susanne Kron Germany 12 90 0.6× 40 0.3× 242 2.4× 179 2.3× 59 1.3× 32 425
Stan Frinak United States 9 65 0.4× 123 1.0× 170 1.7× 59 0.8× 24 0.5× 14 347
Yao-Ping Lin Taiwan 13 54 0.4× 50 0.4× 224 2.2× 96 1.2× 21 0.5× 19 394
Antonio Fortunato Italy 10 29 0.2× 47 0.4× 112 1.1× 86 1.1× 32 0.7× 25 334
Ovidiu Ştiru Romania 9 35 0.2× 116 0.9× 37 0.4× 107 1.4× 60 1.3× 70 328
Hadim Akoğlu Türkiye 12 29 0.2× 49 0.4× 76 0.8× 78 1.0× 43 1.0× 39 337
Amrish Jain United States 10 14 0.1× 45 0.3× 75 0.7× 117 1.5× 33 0.7× 24 318
Anderson Cb United States 11 105 0.7× 148 1.1× 65 0.6× 174 2.2× 13 0.3× 32 329

Countries citing papers authored by Chung‐Wei Yang

Since Specialization
Citations

This map shows the geographic impact of Chung‐Wei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chung‐Wei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chung‐Wei Yang more than expected).

Fields of papers citing papers by Chung‐Wei Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chung‐Wei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chung‐Wei Yang. The network helps show where Chung‐Wei Yang may publish in the future.

Co-authorship network of co-authors of Chung‐Wei Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Chung‐Wei Yang. A scholar is included among the top collaborators of Chung‐Wei Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chung‐Wei Yang. Chung‐Wei Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Donna Shu‐Han, et al.. (2025). Safety and Short-Term Effects of Empagliflozin in Patients with Heart Failure and End-Stage Renal Disease. American Journal of Cardiovascular Drugs. 26(1). 83–96. 1 indexed citations
2.
Hsieh, Mu‐Yang, et al.. (2024). Association of frailty and chronic limb-threatening ischemia in patients on maintenance hemodialysis: a prospective cohort study. Aging. 16(22). 13676–13692. 1 indexed citations
3.
Yang, Chung‐Wei, et al.. (2024). Effects of a Health Literacy Education Program on Mental Health and Renal Function in Patients With Chronic Kidney Disease: A Randomized Controlled Trial. Journal of Nursing Research. 32(1). e310–e310. 2 indexed citations
4.
Wu, Chih‐Cheng, Mu‐Yang Hsieh, Chung‐Wei Yang, et al.. (2024). A randomized controlled trial evaluated the efficacy and safety of apixaban for prevention of recurrent thrombosis after thrombectomy of hemodialysis vascular access. Kidney International. 107(2). 348–358. 1 indexed citations
5.
Chen, Cheng‐Yi, M. C. Lin, Cheng‐Han Lin, et al.. (2023). Studying the Roles of the Renin–Angiotensin System in Accelerating the Disease of High-Fat-Diet-Induced Diabetic Nephropathy in a db/db and ACE2 Double-Gene-Knockout Mouse Model. International Journal of Molecular Sciences. 25(1). 329–329. 3 indexed citations
6.
7.
Yang, Chung‐Wei, et al.. (2019). A randomized feasibility study of the effect of ascorbic acid on post-angioplasty restenosis of hemodialysis vascular access (NCT03524846). Scientific Reports. 9(1). 11095–11095. 8 indexed citations
8.
Yang, Chung‐Wei, Chia‐Chu Chang, Wen-Yeh Hsieh, et al.. (2017). Imbalanced plasma ACE and ACE2 level in the uremic patients with cardiovascular diseases and its change during a single hemodialysis session. Renal Failure. 39(1). 719–728. 18 indexed citations
9.
Hsieh, Mu‐Yang, Lin Lin, Ming‐Hsien Lee, et al.. (2017). Timely thrombectomy can improve patency of hemodialysis arteriovenous fistulas. Journal of Vascular Surgery. 67(4). 1217–1226. 21 indexed citations
10.
Lee, Szu‐Ying, Chung‐Wei Yang, Szu‐Chun Hung, et al.. (2016). A Simpler Creatinine Index Can Predict Long-Term Survival in Chinese Hemodialysis Patients. PLoS ONE. 11(10). e0165164–e0165164. 16 indexed citations
11.
Lin, Ting‐Tse, Mu‐Yang Hsieh, Lin Lin, et al.. (2016). Circulating Progenitor Cells Affect Thrombosis of Dialysis Arteriovenous Fistulas. American Journal of Nephrology. 44(6). 428–438. 5 indexed citations
12.
Wu, Hon‐Yen, Feng‐Jung Yang, Pei‐Chen Wu, et al.. (2016). Proteinuria as a Therapeutic Target in Advanced Chronic Kidney Disease: a Retrospective Multicenter Cohort Study. Scientific Reports. 6(1). 26539–26539. 16 indexed citations
13.
14.
Yeh, F. S., et al.. (2014). Gold nanoparticles conjugates-amplified aptamer immunosensing screen-printed carbon electrode strips for thrombin detection. Biosensors and Bioelectronics. 61. 336–343. 34 indexed citations
15.
Yang, Chung‐Wei, et al.. (2012). Comparisons of clinical outcomes for thrombectomy devices with different mechanisms in hemodialysis arteriovenous fistulas. Catheterization and Cardiovascular Interventions. 80(6). 1035–1041. 32 indexed citations
16.
Yang, Chung‐Wei, et al.. (2011). Coexistence of neuroleptic malignant syndrome and a hyperosmolar hyperglycemic state. The American Journal of Emergency Medicine. 30(5). 833.e1–833.e2. 1 indexed citations
17.
Wu, Chih‐Cheng, et al.. (2009). Plasma ADMA Predicts Restenosis of Arteriovenous Fistula. Journal of the American Society of Nephrology. 20(1). 213–222. 33 indexed citations
18.
19.
Yang, Chung‐Wei, Yung‐Chang Chen, Po Dunn, et al.. (2003). Thrombotic Thrombocytopenic Purpura (TTP): Initial Treatment with Plasma Exchange Plus Steroids and Immunosuppressive Agents for Relapsing Cases. Renal Failure. 25(1). 21–30. 14 indexed citations
20.
Yang, Chung‐Wei, Yung‐Chang Chen, Po Dunn, et al.. (2001). TICLOPIDINE-INDUCED THROMBOTIC THROMBOCYTOPENIC PURPURA: TWO CASE REPORTS TREATED WITH PLASMA EXCHANGE PLUS STEROIDS. Renal Failure. 23(6). 851–856. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Damodar Kumbala Breakdown of academic impact, for papers by Yuji Nagura Breakdown of academic impact, for papers by Susanne Kron Breakdown of academic impact, for papers by Stan Frinak Breakdown of academic impact, for papers by Yao-Ping Lin Breakdown of academic impact, for papers by Antonio Fortunato Breakdown of academic impact, for papers by Ovidiu Ştiru Breakdown of academic impact, for papers by Hadim Akoğlu Breakdown of academic impact, for papers by Amrish Jain Breakdown of academic impact, for papers by Anderson Cb
Rankless by CCL
2026